Hubei Guangji Pharmaceutical Co Ltd Total Liabilities
Hubei Guangji Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Hubei Guangji Pharmaceutical Co Ltd (000952) has total liabilities worth CN¥1.61 Billion CNY (≈ $235.85 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Hubei Guangji Pharmaceutical Co Ltd to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Hubei Guangji Pharmaceutical Co Ltd (1996–2025)
Total liabilities of Hubei Guangji Pharmaceutical Co Ltd from 1996 to 2025. This chart illustrates how Hubei Guangji Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Hubei Guangji Pharmaceutical Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Hubei Guangji Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Hubei Guangji Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ribbon Communications Inc
NASDAQ:RBBN
|
USA | $750.25 Million |
|
Tehmag Foods
TWO:1264
|
Taiwan | NT$1.79 Billion |
|
Trailblazer Acquisition Corp. Class A Ordinary Shares
NASDAQ:BLZR
|
USA | $292.54 Million |
|
Gaotu Techedu Inc
F:18WA
|
Germany | €4.28 Billion |
|
Liton Technology
TWO:6175
|
Taiwan | NT$1.76 Billion |
|
WATERDROP INC.ADS/10 CL.A
F:717
|
Germany | €2.56 Billion |
|
Shanghai Challenge Textile Co Ltd
SHE:002486
|
China | CN¥213.41 Million |
|
Nanjing Wondux Environmental Protection Technology Corp Ltd
SHG:688178
|
China | CN¥1.20 Billion |
Liability Composition Analysis (1996–2025)
This chart breaks down Hubei Guangji Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Hubei Guangji Pharmaceutical Co Ltd's balance sheet.
Liquidity & Leverage Metrics
Hubei Guangji Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Hubei Guangji Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.53 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.70 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.74 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hubei Guangji Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hubei Guangji Pharmaceutical Co Ltd (1996–2025)
The table below shows the annual total liabilities of Hubei Guangji Pharmaceutical Co Ltd from 1996 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.69 Billion ≈ $246.66 Million |
-1.85% |
| 2024-12-31 | CN¥1.72 Billion ≈ $251.31 Million |
+4.91% |
| 2023-12-31 | CN¥1.64 Billion ≈ $239.55 Million |
+67.52% |
| 2022-12-31 | CN¥977.25 Million ≈ $143.00 Million |
+63.39% |
| 2021-12-31 | CN¥598.09 Million ≈ $87.52 Million |
-2.55% |
| 2020-12-31 | CN¥613.75 Million ≈ $89.81 Million |
-23.49% |
| 2019-12-31 | CN¥802.21 Million ≈ $117.39 Million |
-1.25% |
| 2018-12-31 | CN¥812.33 Million ≈ $118.87 Million |
-7.34% |
| 2017-12-31 | CN¥876.65 Million ≈ $128.28 Million |
-10.06% |
| 2016-12-31 | CN¥974.70 Million ≈ $142.63 Million |
-11.94% |
| 2015-12-31 | CN¥1.11 Billion ≈ $161.97 Million |
+2.77% |
| 2014-12-31 | CN¥1.08 Billion ≈ $157.60 Million |
+31.86% |
| 2013-12-31 | CN¥816.78 Million ≈ $119.52 Million |
+2.62% |
| 2012-12-31 | CN¥795.93 Million ≈ $116.47 Million |
+23.77% |
| 2011-12-31 | CN¥643.07 Million ≈ $94.10 Million |
+17.98% |
| 2010-12-31 | CN¥545.06 Million ≈ $79.76 Million |
+11.94% |
| 2009-12-31 | CN¥486.93 Million ≈ $71.25 Million |
+23.03% |
| 2008-12-31 | CN¥395.78 Million ≈ $57.92 Million |
+21.49% |
| 2007-12-31 | CN¥325.76 Million ≈ $47.67 Million |
+5.99% |
| 2006-12-31 | CN¥307.34 Million ≈ $44.97 Million |
-12.36% |
| 2005-12-31 | CN¥350.68 Million ≈ $51.32 Million |
-9.79% |
| 2004-12-31 | CN¥388.76 Million ≈ $56.89 Million |
+10.32% |
| 2003-12-31 | CN¥352.38 Million ≈ $51.56 Million |
+12.56% |
| 2002-12-31 | CN¥313.05 Million ≈ $45.81 Million |
+13.85% |
| 2001-12-31 | CN¥274.96 Million ≈ $40.24 Million |
+41.24% |
| 2000-12-31 | CN¥194.67 Million ≈ $28.49 Million |
-2.41% |
| 1999-12-31 | CN¥199.49 Million ≈ $29.19 Million |
+6.79% |
| 1998-12-31 | CN¥186.80 Million ≈ $27.34 Million |
+11.96% |
| 1997-12-31 | CN¥166.84 Million ≈ $24.41 Million |
+50.69% |
| 1996-12-31 | CN¥110.72 Million ≈ $16.20 Million |
-- |
About Hubei Guangji Pharmaceutical Co Ltd
Hubei Guangji Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical raw materials, pharmaceutical preparations, and feed additives in China and internationally. The company also exports its products. Hubei Guangji Pharmaceutical Co., Ltd. was founded in 1969 and is based in Wuxue, China.